Online Surveys to Assess the Perception and Performance of Imaging and Associated Aspects

Sponsor
Ohio State University (Other)
Overall Status
Recruiting
CT.gov ID
NCT03494335
Collaborator
(none)
5,000
1
20
249.9

Study Details

Study Description

Brief Summary

In this exploratory study, the researchers would like to investigate the background, perception, current use practices, potential unmet needs and/or challenges in regard to imaging procedures, imaging technology, or any other aspect related to the broader field of imaging.

Condition or Disease Intervention/Treatment Phase
  • Other: Online surveys

Detailed Description

The researchers plan to include volunteer participants to complete these surveys. The goal of these exploratory efforts will be to increase the currently very limited information available in the topics of interest stated above, and the findings, even if only from limited group of respondents, will help guide research development, prepare for design of clinical trials, guide special interest groups, and serve as role data for appropriate scientific publications.

Study Design

Study Type:
Observational
Anticipated Enrollment :
5000 participants
Observational Model:
Cohort
Time Perspective:
Retrospective
Official Title:
Online Surveys to Assess the Perception and Performance of Imaging Associated Aspects
Anticipated Study Start Date :
Aug 30, 2022
Anticipated Primary Completion Date :
Apr 30, 2024
Anticipated Study Completion Date :
Apr 30, 2024

Arms and Interventions

Arm Intervention/Treatment
Volunteer participants

Volunteer participants will participate in surveys assessing their perception of various imaging aspects.

Other: Online surveys
The investigators are recruiting health care providers for these surveys that are involved in or use imaging.

Outcome Measures

Primary Outcome Measures

  1. Perception of PET/CT imaging agent Y-90 [through study completion, on average 2-5 years]

    To evaluate participants' perceptions of Y-90 using a likert scale on an online survey

  2. Perception of PET/CT imaging agent NaF [through study completion, on average 2-5 years]

    To evaluate participants' perceptions of NaF using a likert scale on an online survey

  3. Perception of MRI contrast agents [through study completion, on average 2-5 years]

    To evaluate participants' perceptions of MR contrast agents using a likert scale

Eligibility Criteria

Criteria

Ages Eligible for Study:
18 Years and Older
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
Yes
Inclusion Criteria:
  • Male and female participants who have access to the online survey tool and can read and write in English
Exclusion Criteria:
  • None, as this is voluntary

Contacts and Locations

Locations

Site City State Country Postal Code
1 Martha Morehouse Medical Plaza Columbus Ohio United States 43221

Sponsors and Collaborators

  • Ohio State University

Investigators

  • Principal Investigator: Michael V Knopp, MD, PhD, Ohio State University

Study Documents (Full-Text)

More Information

Publications

None provided.
Responsible Party:
Michael V. Knopp MD, PhD, Professor, Ohio State University
ClinicalTrials.gov Identifier:
NCT03494335
Other Study ID Numbers:
  • RP0320_S02/2018E0141
First Posted:
Apr 11, 2018
Last Update Posted:
Apr 19, 2022
Last Verified:
Apr 1, 2022
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
No

Study Results

No Results Posted as of Apr 19, 2022